2023
DOI: 10.14202/vetworld.2023.1222-1230
|View full text |Cite
|
Sign up to set email alerts
|

Realistic aspects behind the application of the rat model of chemically-induced mammary cancer: Practical guidelines to obtain the best results

Abstract: Cancer is one of the most important public health problems worldwide. Despite the great contribution of in-vitro studies for biomedical research, animals are essential to study diseases’ biopathology and diagnosis, and searching for new preventive and therapeutic strategies. Breast cancer is currently the most common cancer globally, accounting for 12.5% of all new annual cancer cases worldwide. Although the rat model of mammary cancer chemically-induced is widely used to study this disease, there is a lack of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…Published studies indicate that MNU generates more aggressive mammary tumors than DMBA in a shorter time [ 130 ]. Sprague-Dawley and Wistar rats are the most commonly used strains in mammary carcinogenesis because they are more susceptible to carcinogenic agents than other strains [ 131 ]. A broad spectrum of hormone-positive histological lesions has been observed in rat models of chemically induced mammary tumors [ 132 ].…”
Section: Nsaids For Breast Cancermentioning
confidence: 99%
“…Published studies indicate that MNU generates more aggressive mammary tumors than DMBA in a shorter time [ 130 ]. Sprague-Dawley and Wistar rats are the most commonly used strains in mammary carcinogenesis because they are more susceptible to carcinogenic agents than other strains [ 131 ]. A broad spectrum of hormone-positive histological lesions has been observed in rat models of chemically induced mammary tumors [ 132 ].…”
Section: Nsaids For Breast Cancermentioning
confidence: 99%